Clinical trial

Midazolam Efficacy/Safety in Pre-Eclamptic C-Section Sedation

NCT07021521

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-04-05

PhaseNA

Study timeline

Study start (actual)2021-04-05Date precision: day

Registry last updated2025-06-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Midazolamunresolved

Pre-eclampsiaunresolved

Cesarean Sectionunresolved

Efficacyunresolved

Safetyunresolved

Interventions

0 mg/kg Midazolam (Control Group)DRUG

0.01 mg/kg Midazolam GroupDRUG

0.02 mg/kg Midazolam GroupDRUG

0.03 mg/kg Midazolam GroupDRUG

Sponsors & collaborators

Zhuji People's Hospital of Zhejiang Provincelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07021521 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.